CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]
Net sales	$ 556	$ 766
Costs and expenses:
Cost of products sold	(207)	(473)
Research and development expense	(16,456)	(11,556)
Selling, general and administrative expense	(5,673)	(6,522)
Operating loss	(21,780)	(17,785)
Other non-operating income, net	91	414
Interest and amortization of debt discount and expense	(26)	(17)
Net foreign exchange (losses)/gains	(219)	1,233
Fair value movement of derivatives	3	2
Loss before income taxes from continuing operations	(21,931)	(16,153)
Income tax (expense)/benefit	0	0
Loss after income tax	(21,931)	(16,153)
Total (loss)/gain is attributable to:
Non-controlling interests	(67)	197
Stockholders of the Company	(21,864)	(16,350)
Loss after income tax	$ (21,931)	$ (16,153)
Share information
Basic loss per share (in Dollars per share)	$ (0.61)	$ (0.91)
Diluted loss per share (in Dollars per share)	$ (0.61)	$ (0.91)